Baru nuts reduce abdominal adiposity in type 2 diabetic adults: a randomized, placebo-controlled crossover trial

被引：0
|
作者：
Cruvinel, Beatriz Assis Carvalho [1 ]
Alves, Ana Gabriella Pereira [2 ]
Schincaglia, Raquel Machado [3 ]
Silva, Maria Sebastiana [2 ]
机构：
[1] Univ Fed Jatai, Assuntos Estudantis, Jatai, GO, Brazil
[2] Univ Fed Goias, Fac Educ Fis & Danca, Lab Fisiol Nutr & Saude, Goiania, GO, Brazil
[3] Univ Fed Goias, Fac Med, Programa Posgrad Ciencias Saude, Goiania, GO, Brazil
来源：
REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION | 2023年 / 36卷
关键词：
Body composition; Diabetes Mellitus; Type 2. Dietary modification; Nuts; Obesity mangements; DIPTERYX-ALATA VOG; INSULIN-RESISTANCE; LIPID PROFILE; OBESE WOMEN; APPETITE; ALMOND; BIOACCESSIBILITY; METABOLISM; GLUCOSE; PLASMA;
D O I：
10.1590/1678-9865202336e220103
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
ObjectiveThis study aimed to evaluate the effect of baru nuts supplementation on body composition and metabolic profile in adults with type 2 diabetes. MethodsThis is a randomized, placebo-controlled, crossover trial with 30 adults with type 2 diabetes. The assay had two periods of 12 weeks each, with a washout period of 12 weeks between treatments. The subjects were randomized and received the two treatments in alternate periods: supplementation of 30g baru nuts or placebo. Anthropometry, body composition, blood pressure, blood sampling, food intake, and physical activity data were analyzed. ResultsBaru nut intake reduced waist circumference (p=0.032), compared to placebo group. In the intra-group analysis, baru nut intake reduced total cholesterol (p=0.012) and LDL-c (p=0.017). ConclusionThe daily intake of baru nuts improved abdominal adiposity. Therefore, these nuts should be included in the diet to improve the health status of adults with type 2 diabetes.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] A Prospective Randomized Placebo-Controlled Crossover Trial of Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
    Kannankeril, Prince J.
    Moore, Jeremy P.
    Cerrone, Marina
    Priori, Silvia G.
    Kertesz, Naomi J.
    Ro, Pam
    Batra, Anjan S.
    Kaufman, Elizabeth S.
    Fairbrother, David L.
    Saarel, Elizabeth V.
    Etherdige, Susan P.
    Kanter, Ronald J.
    Carboni, Michael P.
    Dzurik, Matthew V.
    Fountain, Darlene
    Chen, Heidi
    Ely, E. W.
    Roden, Dan M.
    Knollmann, Bjorn C.
    CIRCULATION, 2016, 134
  • [42] A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma
    Kaler, Maryann
    Barochia, Amisha V.
    Weir, Nargues A.
    Cuento, Rosemarie A.
    Stylianou, Mario
    Roth, Mark J.
    Filie, Armando C.
    Vaughey, Ellen C.
    Nathan, Steven D.
    Levine, Stewart J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (06) : 1716 - 1718
  • [43] Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial
    Hamidovic, A.
    Khafaja, M.
    Brandon, V.
    Anderson, J.
    Ray, G.
    Allan, A. M.
    Burge, M. R.
    MOLECULAR PSYCHIATRY, 2017, 22 (10) : 1413 - 1421
  • [44] Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial
    Donze, Stephany H.
    Kuppens, Renske J.
    Bakker, Nienke E.
    van Alfen-van der Velden, Janielle A. E. M.
    Hokken-Koelega, Anita C. S.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (06) : 806 - 812
  • [45] Effects of blackcurrant extract on arterial functions in older adults: A randomized, double-blind, placebo-controlled, crossover trial
    Okamoto, Takanobu
    Hashimoto, Yuto
    Kobayashi, Ryota
    Nakazato, Koichi
    Willems, Mark Elisabeth Theodorus
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2020, 42 (07) : 640 - 647
  • [46] A Randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients
    Nikander, E
    Kilkkinen, A
    Metsä-Heikkilä, M
    Adlercreutz, H
    Pietinen, P
    Tiitinen, A
    Ylikorkala, O
    OBSTETRICS AND GYNECOLOGY, 2003, 101 (06): : 1213 - 1220
  • [47] A Prospective Randomized Placebo-Controlled Crossover Trial of Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
    Kannankeril, Prince J.
    Moore, Jeremy P.
    Cerrone, Marina
    Priori, Silvia G.
    Kertesz, Naomi J.
    Ro, Pam
    Batra, Anjan S.
    Kaufman, Elizabeth S.
    Fairbrother, David L.
    Saarel, Elizabeth V.
    Etherdige, Susan P.
    Kanter, Ronald J.
    Carboni, Michael P.
    Dzurik, Matthew V.
    Fountain, Darlene
    Chen, Heidi
    Ely, E. W.
    Roden, Dan M.
    Knollmann, Bjorn C.
    CIRCULATION, 2016, 134
  • [48] Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial
    A Hamidovic
    M Khafaja
    V Brandon
    J Anderson
    G Ray
    A M Allan
    M R Burge
    Molecular Psychiatry, 2017, 22 : 1413 - 1421
  • [49] Acute effects of oxytocin in music performance anxiety: a crossover, randomized, placebo-controlled trial
    Sabino, Alini D. V.
    Chagas, Marcos Hortes N.
    Osorio, Flavia L.
    PSYCHOPHARMACOLOGY, 2020, 237 (06) : 1757 - 1767
  • [50] Acute effects of oxytocin in music performance anxiety: a crossover, randomized, placebo-controlled trial
    Alini D. V. Sabino
    Marcos Hortes N. Chagas
    Flávia L. Osório
    Psychopharmacology, 2020, 237 : 1757 - 1767
12345